SWP
AMAG

Stratos Wealth Partners’s AMAG Pharmaceuticals AMAG Stock Holding History

Stratos Wealth Partners’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-200
Closed -$4K – 2824
2018
Q3 		$4K Buy
+200
New +$4.55K ﹤0.01% 2576
2018
Q2 		– Sell
-200
Closed -$4K – 2905
2018
Q1 		$4K Hold
200
– – ﹤0.01% 2715
2017
Q4 		$3K Buy
+200
New +$3.02K ﹤0.01% 2566

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Stratos Wealth Partners's AMAG Position: Q4 2018 in Review

Stratos Wealth Partners sold out of AMAG Pharmaceuticals (AMAG) in Q4 2018, closing a stake of 200 shares — an estimated $4K sold.

Stratos Wealth Partners first reported a position in AMAG in Q4 2017 and held it in 3 quarters. The position peaked at $4K in Q3 2018. 190 funds tracked by Wall St. Rank hold AMAG as of Q4 2018.

  • Stratos Wealth Partners reported no remaining AMAG Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Stratos Wealth Partners sold 200 AMAG Pharmaceuticals shares in Q4 2018, an estimated $4K.
  • Stratos Wealth Partners first reported a position in AMAG Pharmaceuticals in Q4 2017 and held it in 3 quarters.
  • Stratos Wealth Partners's AMAG Pharmaceuticals position peaked at $4K in Q3 2018.
  • 190 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2018.

Based on Stratos Wealth Partners's 13F filing for Q4 2018, filed 8 Feb 2019.